Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Chagas disease	4/102	4.7476288106462685e-06	0.00029910061507071496	54.21768707482993	-134.5540755438832	TGFB1;TGFBR1;TGFBR2;TLR4
KEGG_2021_Human	Hepatitis B	4/162	2.979383554686203e-05	0.0006410246162706156	33.37552742616034	-89.36652156273904	TGFB1;TGFBR1;TGFBR2;TLR4
KEGG_2021_Human	Hippo signaling pathway	4/163	3.052498172717217e-05	0.0006410246162706156	33.16142557651992	-88.86135909767627	CCN2;TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Pancreatic cancer	3/76	9.159620399517935e-05	0.0011541121703392597	46.93737769080235	-88.55605413655218	TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Chronic myeloid leukemia	3/76	9.159620399517935e-05	0.0011541121703392597	46.93737769080235	-88.55605413655218	TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Colorectal cancer	3/86	0.0001324740846980751	0.0013909778893297887	41.230636833046475	-79.65388581050792	TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	TGF-beta signaling pathway	3/94	0.00017260861398757182	0.0015534775258881463	37.56828885400314	-73.71479219141467	TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	3/100	0.00020740615092509237	0.0016333234385351024	35.2179675994109	-69.8003308229761	TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Th17 cell differentiation	3/107	0.0002534260244380865	0.0017739821710666054	32.81868131868132	-65.71442008901244	TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	MAPK signaling pathway	4/294	0.0003034351122757725	0.0019116412073373668	17.880459770114943	-49.762697732575255	MAPT;TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Relaxin signaling pathway	3/129	0.00043986806704120836	0.0022302407258966836	27.01360544217687	-55.40965280021221	TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	FoxO signaling pathway	3/131	0.0004602084037564585	0.0022302407258966836	26.584821428571427	-54.62268457986884	TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Osteoclast differentiation	3/127	0.0004201187826005964	0.0022302407258966836	27.456221198156683	-56.21805005538481	TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Gastric cancer	3/149	0.0006711090600743852	0.0030199907703347332	23.25440313111546	-48.37496566440217	TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Cellular senescence	3/156	0.0007673816433603202	0.0032230029021133454	22.170868347338935	-46.2873867313738	TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Hepatocellular carcinoma	3/168	0.0009522461559574535	0.003749469239082473	20.527272727272727	-43.06507884394289	TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Malaria	2/50	0.0016370061401984127	0.005764241830910568	41.770833333333336	-50.1560330081587	TGFB1;TLR4
KEGG_2021_Human	Diabetic cardiomyopathy	3/203	0.0016469262374030193	0.005764241830910568	16.86	-35.61063787888018	TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	3/219	0.0020484263518845244	0.006792150535196055	15.579365079365079	-32.91284230349772	TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Inflammatory bowel disease	2/65	0.002752148243719554	0.008669266967716594	31.765873015873016	-40.07734547796954	TGFB1;TLR4
KEGG_2021_Human	Adherens junction	2/71	0.0032750085301139972	0.009825025590341992	28.981884057971016	-37.08506032826052	TGFBR1;TGFBR2
KEGG_2021_Human	Leishmaniasis	2/77	0.0038409427449733026	0.010999063315150822	26.643333333333334	-34.49723066158141	TGFB1;TLR4
KEGG_2021_Human	Cytokine-cytokine receptor interaction	3/295	0.004778958454651453	0.013090190549697458	11.412915851272016	-23.74866982495136	TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Rheumatoid arthritis	2/93	0.005556617161068888	0.014586120047805832	21.914835164835164	-29.03004575134454	TGFB1;TLR4
KEGG_2021_Human	Amoebiasis	2/102	0.006650847322673755	0.016760135253137864	19.92	-26.61700675496218	TGFB1;TLR4
KEGG_2021_Human	Toxoplasmosis	2/112	0.007973056255711614	0.019319328619608913	18.086363636363636	-24.33571316400054	TGFB1;TLR4
KEGG_2021_Human	Apelin signaling pathway	2/137	0.011753397776716717	0.02742459481233901	14.690740740740742	-19.931093924152265	CCN2;TGFBR1
KEGG_2021_Human	Tuberculosis	2/180	0.019755026308062106	0.04444880919313974	11.081460674157304	-14.950240051620256	TGFB1;TLR4
KEGG_2021_Human	Pathways in cancer	3/531	0.02393281759639253	0.051991983054232055	6.12012987012987	-11.164029011261546	TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Proteoglycans in cancer	2/205	0.025220492252545426	0.052963033730345395	9.685960591133005	-12.928804077098514	TGFB1;TLR4
KEGG_2021_Human	Endocytosis	2/252	0.036977605273484586	0.07514803652353319	7.818	-10.130623353400585	TGFBR1;TGFBR2
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.05788809587819119	0.11396718876018891	18.962174940898347	-11.032973182262484	TGFB1
KEGG_2021_Human	Legionellosis	1/57	0.06840002327828267	0.130581862622176	15.896825396825397	-9.424000900813787	TLR4
KEGG_2021_Human	Renal cell carcinoma	1/69	0.08225170002715665	0.15240756181502557	13.071895424836601	-7.854937277937848	TGFB1
KEGG_2021_Human	Pertussis	1/76	0.09024597396088518	0.16244275312959333	11.841481481481482	-7.141387005986298	TLR4
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	1/89	0.10492639565254669	0.18056613582674566	10.075757575757576	-6.080768259179883	TLR4
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.18056613582674566	9.961298377028713	-6.010407578745034	TGFB1
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.18691537772485436	9.32514619883041	-5.615549699272252	TGFB1
KEGG_2021_Human	Toll-like receptor signaling pathway	1/104	0.12160016340314761	0.1915202573599575	8.592233009708737	-5.152341092635986	TLR4
KEGG_2021_Human	NF-kappa B signaling pathway	1/104	0.12160016340314761	0.1915202573599575	8.592233009708737	-5.152341092635986	TLR4
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.19529330169742887	8.189300411522634	-4.893732148578802	TLR4
KEGG_2021_Human	Cell cycle	1/124	0.14339691916847833	0.2150953787527175	7.177055103884372	-4.231046804704064	TGFB1
KEGG_2021_Human	Yersinia infection	1/137	0.15730251033809037	0.2282657578083977	6.480392156862745	-3.763669230249352	TLR4
KEGG_2021_Human	Measles	1/139	0.15942370386618251	0.2282657578083977	6.384863123993559	-3.698840756963446	TLR4
KEGG_2021_Human	Non-alcoholic fatty liver disease	1/155	0.17622102470306392	0.23621116077219206	5.70995670995671	-3.235678410841787	TGFB1
KEGG_2021_Human	Cell adhesion molecules	1/148	0.16890973234869874	0.23621116077219206	5.987150415721844	-3.427000500776257	L1CAM
KEGG_2021_Human	Phagosome	1/152	0.17309473207732412	0.23621116077219206	5.82560706401766	-3.3156870475343334	TLR4
KEGG_2021_Human	Necroptosis	1/159	0.18037286671285227	0.23673938756061863	5.562587904360056	-3.1333425612983894	TLR4
KEGG_2021_Human	Influenza A	1/172	0.1937366175133076	0.24908993680282404	5.131254061078622	-2.8313674486945275	TLR4
KEGG_2021_Human	NOD-like receptor signaling pathway	1/181	0.20287322552436027	0.25185501362336565	4.869135802469136	-2.6461154603833723	TLR4
KEGG_2021_Human	Axon guidance	1/182	0.2038826300760579	0.25185501362336565	4.841620626151013	-2.6265948500338347	L1CAM
KEGG_2021_Human	Neutrophil extracellular trap formation	1/189	0.21091631211370437	0.2542746424287351	4.657210401891253	-2.4954112144854435	TLR4
KEGG_2021_Human	Transcriptional misregulation in cancer	1/192	0.21391358807496763	0.2542746424287351	4.5823152995927865	-2.441961042053517	TGFBR2
KEGG_2021_Human	Pathogenic Escherichia coli infection	1/197	0.21888628489075546	0.25536733237254805	4.462585034013605	-2.3563138595912863	TLR4
KEGG_2021_Human	Human immunodeficiency virus 1 infection	1/212	0.23363497492364255	0.2661237648230343	4.137440758293839	-2.12256354972075	TLR4
KEGG_2021_Human	Lipid and atherosclerosis	1/215	0.23655445762047492	0.2661237648230343	4.077881619937695	-2.079575623138921	TLR4
KEGG_2021_Human	Coronavirus disease	1/232	0.25290994493508406	0.279532044401935	3.7696007696007694	-1.8563524399324505	TLR4
KEGG_2021_Human	Salmonella infection	1/249	0.2689494049142217	0.2823968751599328	3.503584229390681	-1.6629804039719844	TLR4
KEGG_2021_Human	Shigellosis	1/246	0.26614163456811335	0.2823968751599328	3.547845804988662	-1.6951894904190261	TLR4
KEGG_2021_Human	Parkinson disease	1/249	0.2689494049142217	0.2823968751599328	3.503584229390681	-1.6629804039719844	MAPT
KEGG_2021_Human	PI3K-Akt signaling pathway	1/354	0.36133488698431165	0.3731819324592071	2.4283915643689014	-0.883914601009246	TLR4
KEGG_2021_Human	Alzheimer disease	1/369	0.3736370340305108	0.37966343780519646	2.32487922705314	-0.8103995559567543	MAPT
KEGG_2021_Human	Pathways of neurodegeneration	1/475	0.45466905008847364	0.45466905008847364	1.7801218940459447	-0.4367315309409891	MAPT
